FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: AGENCY INFORMATION COLLECTION ACTIVITIES; PROPOSED COLLECTION; COMMENT REQUEST; CURRENT GOOD MANUFACTURING PRACTICE (CGMP): MANUFACTURING, PROCESSING, PACKING, AND HOLDING OF DRUGS; GMP FOR FINISHED PHARMACEUTICALS (INCLUDING ACTIVE PHARMACEUTICAL INGREDIENTS) AND THE ADVANCED MANUFACTURING TECHNOLOGIES DESIGNATION PROGRAM

WASHINGTON, Feb. 20 -- Food and Drug Administration has issued a notice called: Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice (CGMP): Manufacturing, Processing, Packing, and Holding of Drugs; GMP for Finished Pharmaceuticals (Including Active Pharmaceutical Ingredients) and the Advanced Manufacturing Technologies Designation Program.

The notice was published in the Federal Register on Feb. 20 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork...